Skip to main content
Top
Published in: Esophagus 2/2017

Open Access 01-04-2017 | Original Article

Re-evaluation of the role of thoracoscopic esophagectomy as a Japanese-style radical surgery

Authors: Harushi Udagawa, Masaki Ueno, Shusuke Haruta, Tsuyoshi Tanaka, Aya Mizuno, Yu Ohkura

Published in: Esophagus | Issue 2/2017

Login to get access

Abstract

Purpose

To investigate the value of thoracoscopic surgery in radical esophagectomy with three-field lymphadenectomy.

Materials and method

The subjects were 329 consecutive patients who, without preoperative chemoradiotherapy, underwent R0 radical esophagectomy with three-field lymphadenectomy for thoracic squamous cell esophageal cancers during 1998–2013. Open thoracotomy was applied in 212 (O), and thoracoscopic surgery in 117 (V). Survivals according to TNM Stages and Efficacy index (EI) were analyzed.

Results

Hospital death rates of O/V were 1.9/0%. The survivals of V according to TNM Stages had significantly better prognosis in TNM6th cStage III and showed not worse prognosis in general. In the analysis using Cox proportional hazards model, “V or O” was a significant prognostic factor indicating better prognosis of V. More bilateral paratracheal lymph nodes along the recurrent laryngeal nerves tended to be classified as mediastinal instead of cervical in V. Efficacy index of mediastinal paratracheal nodes was higher in V than in O, while cervical lymphadenectomy maintained high EI.

Discussion and conclusion

Though our series have limitations of retrospective study and substantial bias, the feasibility and safety of thoracoscopic esophagectomy with three-field lymphadenectomy was shown. Higher paratracheal lymph nodes along the recurrent laryngeal nerves could be dissected from the mediastinal side in V group. Thoracoscopic esophagectomy, which is regarded as minimally invasive surgery in other countries, is being accepted in Japan mainly in the expectation of more thorough and meticulous lymphadenectomy. At the same time, the dissection range is continuously re-evaluated for safer surgery maintaining radicality.
Literature
1.
go back to reference Udagawa H, Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus. 2001;14:110–4.CrossRefPubMed Udagawa H, Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus. 2001;14:110–4.CrossRefPubMed
2.
go back to reference Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.CrossRefPubMed Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.CrossRefPubMed
4.
go back to reference Perry Y, Fernando HC. Three-field minimally invasive esophagectomy: current results and technique. J Thorac Cardiovasc Surg. 2012;144:S63–6.CrossRefPubMed Perry Y, Fernando HC. Three-field minimally invasive esophagectomy: current results and technique. J Thorac Cardiovasc Surg. 2012;144:S63–6.CrossRefPubMed
5.
go back to reference Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92.CrossRefPubMed Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92.CrossRefPubMed
6.
go back to reference Udagawa H, Ueno M, Kinoshita Y. Rationale for video-assisted radical esophagectomy. Gen Thorac Cardiovasc Surg. 2009;57:127–31.CrossRefPubMed Udagawa H, Ueno M, Kinoshita Y. Rationale for video-assisted radical esophagectomy. Gen Thorac Cardiovasc Surg. 2009;57:127–31.CrossRefPubMed
7.
go back to reference Ninomiya I, Osugi H, Fujimura T, et al. Thoracoscopic esophagectomy with extended lymph node dissection in the left lateral position: technical feasibility and oncologic outcomes. Dis Esophagus. 2014;27:159–67.CrossRefPubMed Ninomiya I, Osugi H, Fujimura T, et al. Thoracoscopic esophagectomy with extended lymph node dissection in the left lateral position: technical feasibility and oncologic outcomes. Dis Esophagus. 2014;27:159–67.CrossRefPubMed
8.
go back to reference Akiyama H. Squamous cell carcinoma of the thoracic esophagus. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins; 1990. p. 19–42. Akiyama H. Squamous cell carcinoma of the thoracic esophagus. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins; 1990. p. 19–42.
9.
go back to reference Osugi H, Takemura M, Lee S, et al. Thoracoscopic esophagectomy for intrathoracic esophageal cancer. Ann Thorac Cardiovasc Surg. 2005;11:221–7.PubMed Osugi H, Takemura M, Lee S, et al. Thoracoscopic esophagectomy for intrathoracic esophageal cancer. Ann Thorac Cardiovasc Surg. 2005;11:221–7.PubMed
10.
go back to reference Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed
11.
go back to reference International Union Against Cancer. Oesophagus. In: Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. Hoboken: Wiley-Lis; 2002. p. 60–4. International Union Against Cancer. Oesophagus. In: Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. Hoboken: Wiley-Lis; 2002. p. 60–4.
12.
go back to reference International Union Against Cancer. Oesophagus including oesophagogastric junction. In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tomours. 7th ed. Hoboken: Wiley-Blackwell; 2009. p. 66–72. International Union Against Cancer. Oesophagus including oesophagogastric junction. In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tomours. 7th ed. Hoboken: Wiley-Blackwell; 2009. p. 66–72.
13.
go back to reference Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef
14.
go back to reference Nakamura K, Kato K, Igaki H, et al. Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study). Jpn J Clin Oncol. 2013;43:752–5.CrossRefPubMed Nakamura K, Kato K, Igaki H, et al. Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study). Jpn J Clin Oncol. 2013;43:752–5.CrossRefPubMed
Metadata
Title
Re-evaluation of the role of thoracoscopic esophagectomy as a Japanese-style radical surgery
Authors
Harushi Udagawa
Masaki Ueno
Shusuke Haruta
Tsuyoshi Tanaka
Aya Mizuno
Yu Ohkura
Publication date
01-04-2017
Publisher
Springer Japan
Published in
Esophagus / Issue 2/2017
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-016-0567-z

Other articles of this Issue 2/2017

Esophagus 2/2017 Go to the issue